PharmaNutra SpA's market cap is currently €533.42M. The company's EPS TTM is €1.693; its P/E ratio is 32.54; and it has a dividend yield of 1.57%. PharmaNutra SpA is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is €0.54. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 101.03M	€ 83.39M	€ 68.58M	€ 58.48M	€ 53.81M
Gross Profit	€ 48.95M	€ 30.17M	€ 25.33M	€ 21.30M	€ 18.06M
Operating Income	€ 23.36M	€ 23.04M	€ 18.69M	€ 13.33M	€ 12.27M
EBITDA	€ 26.53M	€ 24.61M	€ 19.30M	€ 15.10M	€ 12.92M
Net Income	€ 12.83M	€ 15.05M	€ 13.77M	€ 14.07M	€ 8.45M
Balance Sheet
Cash & Short-Term Investments	€ 25.12M	€ 26.86M	€ 33.94M	€ 20.80M	€ 18.83M
Total Assets	€ 112.44M	€ 100.16M	€ 71.36M	€ 51.71M	€ 48.86M
Total Debt	€ 28.02M	€ 17.73M	€ 6.35M	€ 1.66M	€ 6.40M
Net Debt	€ 9.09M	€ -4.33M	€ -23.06M	€ -14.80M	€ -7.35M
Total Liabilities	€ 58.04M	€ 49.21M	€ 26.27M	€ 13.98M	€ 20.73M
Stockholders' Equity	€ 54.41M	€ 50.95M	€ 45.08M	€ 37.73M	€ 28.13M
Cash Flow
Free Cash Flow	€ -1.16M	€ -8.69M	€ 15.43M	€ 10.46M	€ 7.12M
Operating Cash Flow	€ 12.09M	€ 14.47M	€ 20.41M	€ 11.79M	€ 11.98M
Investing Cash Flow	€ -14.70M	€ -23.71M	€ -5.54M	€ -598.00K	€ -5.28M
Financing Cash Flow	€ -516.00K	€ 1.89M	€ -1.92M	€ -4.73M	€ -9.26M

Currency in EUR

PharmaNutra SpA Earnings and Revenue History

Income Statement >

PharmaNutra SpA Debt to Assets

Balance Sheet >

PharmaNutra SpA Cash Flow

Cash Flow >

PharmaNutra SpA Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing